APPLICATIONS PUBLISHED 3 MARCH 2004
Published: 1-Aug-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Formation comprising melt granules of NSAIDS and organic acids
The Boots Company 1392240*
System for osmotic delivery of pharmaceutically active agents
Shire Laboratories 1392241*
Methods of forming an aerosol for inhalation delivery
Alexza Molecular Delivery 1392242*
Topical compsn with a lamellar double-membrane structure, containing a N-acyl-ethanolamine and/or quaternary ammonium salt and/or an adenosylmethionine
Kuhs 1392243*
Pharmaceutical compsns
Novartis 1392244*
Process for making protein delivery matrix and uses thereof
Universite Laval 1392245*
Compaction process for manufacture of sodium phenytoin dosage form
Warner-Lambert 1392246*
Process for preparing granular compsns
The Boots Company 1392247*
Homogenised product for implants and microparticles
Hexal 1392248*
NSAID formulation comprising a granular composition and an extra-granular composition
The Boots Company 1392249*
Controlled release dosage forms forms using acrylic polymer, and process for making the same
Endo Pharmaceuticals 1392250*
Method of tablet enrobing
Bioprocess Technology International 1392251*
Pharmaceutical compsn containing stool softener such as polaxamer and enteric coated particles of bisacodyl
Euro-Celtique 1392252*
Gelatin substitute
Croda International 1392253*
Micellar drug delivery system for hydrophobic drugs
The University of British Columbia 1392254*
Nanoparticles made of protein with coupled apolipoprotein E for penetration of the blood-brain barrier and methods for the production thereof
LTS Lohmann Therapie-Systeme 1392255*
Improved transdermal therapeutic system for the treatment of Parkinson's disease
Schwartz Pharma 1392256*
Delivery of antihistamines through an inhalation route
Alexza Molecular Delivery 1392257*
Delivery of alprazolam, estazolam, midazolam or triazolam through inhalation route
Alexza Molecular Delivery 1392258*
Delivery or erectile dysfunction drugs through an inhalation route
Alexza Molecular Delivery 1392259*
Delivery of benzodiazepines through an inhalation route
Alexza Molecular Delivery 1392260*
Delivery of nonsteroidal inflammatory drugs through an inhalation route
Alexza Molecular Delivery 1392261*
Delivery of drug esters through an inhalation route
Alexza Molecular Delivery 1392262*
Delivery of aerosols containing small particles through an inhalation route
Alexza Molecular Delivery 1392263*
Delivery of antiemetics through an inhalation route
Alexza Molecular Delivery 1392264*
Inhibitors of ABC drug transporters at the blood-brain barrier
Pain Therapeutics 1392265*
Cancer treatment method and compsns comprising compounds of the ginger family
Regents of the University of Minnesota 1392266*
Preventative or remedy for diseases caused by cerebrovascular disturbances
Meiji Dairies 1392267*
Medicament containing a polyamine as an active substance
Bayer HealthCare 1392268*
Novel arylaminopropane analogues and their uses for the treatment of glaucoma
Alcon 1392269*
Abuse resistant pharmaceutical compsn containing capsaicin
Endo Pharmaceuticals 1392270*
Swallow tablet comprising paracetamol
SmithKline Beecham 1392271*
Permeation enhancers
Elan Corp 1392272*
Novel treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
Brookhaven Science Associates 1392273*
Improved dosage form of N-acetyl cysteine
Noveon IP Holdings 1392274*
Use of protein and essential amino acids to treat amenorrhea and related disorders
Novartis Nutrition 1392275*
Potentiation of therapeutic effects of polyunsaturated fatty acids
Laxdale 1392276*
Pharmaceutical compsn comprising a HMG-CoA reductase inhibitor
Sandoz 1392277*
Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
Martek Biosciences 1392278*
Trimethyl lock based tetrapartate prodrugs
Enzon 1392279*
Arylsulphonamide esters and methods of use thereof
Abbott 1392280*
